Wells Fargo & Company Enochian Biosciences Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 18,189 shares of ENOB stock, worth $83,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,189

Previous 17,739 2.54%

Holding current value

$83,669

Previous $81,000 2.47%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	N/A	450 Added 2.54%	18,189 $83,000
Q2 2024 Aug 13, 2024	BUY	N/A	17,445 Added 5933.67%	17,739 $81,000
Q1 2024 May 10, 2024	BUY	N/A	7 Added 2.44%	294 $1,000
Q4 2023 Feb 09, 2024	BUY	$4.3 - $4.7 $313 - $343	73 Added 34.11%	287 $1,000
Q3 2023 Nov 13, 2023	SELL	$0.0 - $4.46 $0 - $1,217	-273 Reduced 56.06%	214 $0
Q2 2023 Aug 15, 2023	SELL	$0.4 - $1.3 $1,194 - $3,881	-2,986 Reduced 85.98%	487 $0
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $3,160 - $4,549	3,473 New	3,473 $3,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.86 $353 - $594	-208 Reduced 94.55%	12 $0
Q2 2022 Aug 12, 2022	BUY	$1.93 - $8.73 $243 - $1,099	126 Added 134.04%	220 $0
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $4 - $9	1 Added 1.08%	94 $1,000
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $6 - $12	1 Added 1.09%	93 $1,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $13 - $23	-3 Reduced 3.16%	92 $1,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $13,812 - $31,899	-4,698 Reduced 98.02%	95 $0
Q1 2021 May 13, 2021	SELL	$3.02 - $4.51 $52,418 - $78,280	-17,357 Reduced 78.36%	4,793 $17,000
Q4 2020 Feb 09, 2021	SELL	$2.82 - $3.55 $48,484 - $61,035	-17,193 Reduced 43.7%	22,150 $65,000
Q3 2020 Nov 05, 2020	SELL	$3.42 - $4.55 $8,515 - $11,329	-2,490 Reduced 5.95%	39,343 $141,000
Q2 2020 Aug 13, 2020	BUY	$2.78 - $6.06 $25,478 - $55,539	9,165 Added 28.05%	41,833 $176,000
Q1 2020 May 14, 2020	BUY	$2.08 - $5.41 $67,949 - $176,733	32,668 New	32,668 $98,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14.7M

Call Options Held

24K

Put Options Held

19.1K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Enochian Biosciences Inc Transaction History